TRADE NEWS: Agilent Technologies Introduces Dissolution Apparatus for Pharmaceutical Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly ...
Agilent Technologies Inc. has introduced an enhanced version of its Dissolution Workstation Software, providing better data integration, method change control and instrument monitoring for controlling ...
Agilent Technologies Inc. has introduced the Cary 8454 UV Dissolution System, which incorporates new Cary 8454 UV-Vis Spectrophotometer technology and enables researchers to sample the entire UV ...
The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...
System addresses the pharmaceutical industry’s need for compliant, semi-automated testing of nanoparticle drug formulations. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results